X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs FDC LTD. - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE FDC LTD. CADILA HEALTHCARE/
FDC LTD.
 
P/E (TTM) x 17.6 18.7 94.3% View Chart
P/BV x 4.0 3.7 105.6% View Chart
Dividend Yield % 1.0 1.3 82.0%  

Financials

 CADILA HEALTHCARE   FDC LTD.
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
FDC LTD.
Mar-14
CADILA HEALTHCARE/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs558144 388.9%   
Low Rs36279 457.6%   
Sales per share (Unadj.) Rs116.347.6 244.5%  
Earnings per share (Unadj.) Rs17.97.6 234.8%  
Cash flow per share (Unadj.) Rs23.19.0 256.7%  
Dividends per share (Unadj.) Rs3.502.25 155.6%  
Dividend yield (eoy) %0.82.0 37.6%  
Book value per share (Unadj.) Rs85.447.5 179.7%  
Shares outstanding (eoy) m1,023.74177.83 575.7%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.02.3 169.0%   
Avg P/E ratio x25.714.6 176.0%  
P/CF ratio (eoy) x19.912.3 161.0%  
Price / Book Value ratio x5.42.3 230.0%  
Dividend payout %19.629.6 66.2%   
Avg Mkt Cap Rs m470,66419,784 2,379.1%   
No. of employees `00011.8NA-   
Total wages/salary Rs m18,5451,221 1,519.5%   
Avg. sales/employee Rs Th10,072.7NM-  
Avg. wages/employee Rs Th1,569.1NM-  
Avg. net profit/employee Rs Th1,547.7NM-  
INCOME DATA
Net Sales Rs m119,0498,459 1,407.4%  
Other income Rs m1,132394 287.6%   
Total revenues Rs m120,1818,852 1,357.7%   
Gross profit Rs m28,4752,070 1,375.5%  
Depreciation Rs m5,388249 2,163.0%   
Interest Rs m91131 2,937.8%   
Profit before tax Rs m23,3082,184 1,067.4%   
Minority Interest Rs m6280-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644606 932.0%   
Profit after tax Rs m18,2921,353 1,351.8%  
Gross profit margin %23.924.5 97.7%  
Effective tax rate %24.227.7 87.3%   
Net profit margin %15.416.0 96.0%  
BALANCE SHEET DATA
Current assets Rs m82,0054,355 1,882.9%   
Current liabilities Rs m60,7201,792 3,388.6%   
Net working cap to sales %17.930.3 59.0%  
Current ratio x1.42.4 55.6%  
Inventory Days Days7344 164.5%  
Debtors Days Days9825 398.5%  
Net fixed assets Rs m83,7033,025 2,767.0%   
Share capital Rs m1,024179 573.3%   
"Free" reserves Rs m86,4218,243 1,048.5%   
Net worth Rs m87,4458,453 1,034.5%   
Long term debt Rs m25,55111 238,794.4%   
Total assets Rs m180,65310,557 1,711.2%  
Interest coverage x26.671.4 37.2%   
Debt to equity ratio x0.30 23,083.4%  
Sales to assets ratio x0.70.8 82.2%   
Return on assets %10.613.1 81.1%  
Return on equity %20.916.0 130.7%  
Return on capital %22.023.5 93.5%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m42,6831,146 3,724.2%   
Fx outflow Rs m11,242355 3,164.1%   
Net fx Rs m31,441791 3,975.8%   
CASH FLOW
From Operations Rs m9,1931,485 619.1%  
From Investments Rs m-9,737-620 1,571.8%  
From Financial Activity Rs m515-753 -68.4%  
Net Cashflow Rs m-29113 -25.7%  

Share Holding

Indian Promoters % 74.8 68.9 108.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 4.7 176.6%  
FIIs % 5.9 7.5 78.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 19.0 57.9%  
Shareholders   44,069 23,730 185.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  ABBOTT INDIA  PLETHICO PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views on News

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 20, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS